Processing Magazine

Allergan Loses $212 Million Lawsuit Over Botox Side Effects

May 2, 2011

According to Bloomberg, Allergan Inc. was ordered by a Virginia jury to pay $212 million to a 67-year-old man who said he got permanent brain damage after being injected with Botox to treat cramps and tremors in his hand in 2007. The Richmond federal jury today awarded Douglas M. Ray $12 million in compensatory damages and $200 million in punitive damages, according to a verdict form provided by the court. Ray, of Fredericksburg, Virginia, said Allergan failed to warn him that injections could trigger an autoimmune reaction leading to brain damage. Botox use left him disabled, Ray said. Allergan denied a failure to warn or any connection between Ray’s illness and Botox use. Botox is Allergan’s top-selling drug, with $1.42 billion in sales last year, or 29 percent of the drugmaker’s revenue, according to data collected by Bloomberg.